Ftse Mib
34.294,67
-0,24%
DAX
18.494,03
-0,57%
S&P 500
5.642,29
0,20%
NASDAQ
18.479,92
0,04%
Bitcoin
63.655,00
-1,84%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
13/11/201922:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
13/11/201913:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2019 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
12/11/201913:00GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Pricing of $20 Million Private Placement of Common StockNASDAQ:APLTApplied Therapeutics Inc
16/10/201913:00GlobeNewswire Inc.Applied Therapeutics to Present Data Highlighting AT-007 for the Treatment of Galactosemia at the American Society of Human G...NASDAQ:APLTApplied Therapeutics Inc
17/09/201913:00GlobeNewswire Inc.Applied Therapeutics to Present Preclinical Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the 55th...NASDAQ:APLTApplied Therapeutics Inc
13/09/201913:00GlobeNewswire Inc.Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the Heart Failure So...NASDAQ:APLTApplied Therapeutics Inc
04/09/201913:00GlobeNewswire Inc.Applied Therapeutics Announces Initiation of Phase 3 Registrational Trial of AT-001 in Diabetic Cardiomyopathy (ARISE-HF)NASDAQ:APLTApplied Therapeutics Inc
28/08/201913:00GlobeNewswire Inc.Applied Therapeutics to Present at Baird’s 2019 Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
12/08/201913:00GlobeNewswire Inc.Applied Therapeutics Reports Second Quarter 2019 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
08/08/201913:00GlobeNewswire Inc.Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia StudyNASDAQ:APLTApplied Therapeutics Inc
24/06/201913:00GlobeNewswire Inc.Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
21/06/201913:00GlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2019 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
07/06/201913:30GlobeNewswire Inc.Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy in Late Breaking Sessio...NASDAQ:APLTApplied Therapeutics Inc
28/05/201913:30GlobeNewswire Inc.Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
24/05/201913:00GlobeNewswire Inc.Applied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective Aldose Reductase Inhibitor ...NASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

NASDAQ
NNAGU
99 Acquisition
BIT
S32149
Societe Generale Effekten
LSE
0KYZ
Sba Communications
TSXV
GBR
Great Bear Resources
LSE
AFP
African Pioneer
NYSE
ERF
Enerplus
NYSE
PBA
Pembina Pipeline
LSE
ESG
Eservglobal
LSE
KIBO
Kibo Energy
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network